Abstract
Cellular therapy has become a billion-dollar industry and is set to become one of the therapeutic pillars of healthcare in the 21st century. Adult stem cells, which include haematopoietic stem and progenitor cells (HSPCs) and mesenchymal stromal/stem cells (MSCs), is one of the major cell types currently under investigation for use in cell therapy. This review focuses on HSPCs and MSCs and discusses their heterogeneous nature and the problems faced in expanding these cells to therapeutic numbers for use in clinical applications.
Cite
CITATION STYLE
Wolmarans, E., Mellet, J., Ambele, M. A., Durandt, C., & Pepper, M. S. (2019, September 10). Heterogeneity of cell therapy products. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde. NLM (Medline). https://doi.org/10.7196/SAMJ.2019.v109i8b.13822
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
